Showing results (151-160 of 175) with videos related to

Sort By:
Pageof 18
Annals of Clinical and Translational Neurology|January 4, 2018
Infectious risk stratification in multiple sclerosis patients receiving immunotherapyJonas Graf, Verena I Leussink, Thomas Dehmel, et al.
Plos One|December 1, 2018
Human lung tissue provides highly relevant data about efficacy of new anti-asthmatic drugsOlga Danov, Sharon Melissa Jiménez Delgado, Helena Obernolte, et al.
European Journal of Immunology|September 15, 2025
Activation of CD8⁺ T Cells in the Human Ex Vivo Lung Tumor Microenvironment Using Anti-CD3/CD28 and NivolumabTonia Bargmann, Sebastian Konzok, Renato Liguori, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 14, 2020
End Points for Clinical Trials in Primary HyperoxaluriaDawn S Milliner, Tracy L McGregor, Aliza Thompson, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 16, 2020
Molecular epidemiological typing of Neisseria gonorrhoeae isolates identifies a novel association between genogroup G10557 (G7072) and decreased susceptibility to cefixime, Germany, 2014 to 2017Sebastian Banhart, Klaus Jansen, Susanne Buder, et al.
Human Molecular Genetics|October 4, 2011
Charcot-Marie-Tooth disease CMT4A: GDAP1 increases cellular glutathione and the mitochondrial membrane potentialRebecca Noack, Svenja Frede, Philipp Albrecht, et al.
Journal of the American Society of Nephrology : JASN|December 16, 2014
Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis: The EVOLVE TrialSharon M Moe, Safa Abdalla, Glenn M Chertow, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 25, 2015
The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) TrialPatrick S Parfrey, Tilman B Drüeke, Geoffrey A Block, et al.
Pageof 18